[contentcards url=”https://www.zerohedge.com/covid-19/pfizer-submits-phase-1-data-booster-jab-trial-fda” target=”_blank”] by TYLER DURDEN Eager to cash in on the promise of a lucrative market for booster doses of its popular COVID vaccine, Pfizer…
May 11, 2026
[contentcards url=”https://www.zerohedge.com/covid-19/pfizer-submits-phase-1-data-booster-jab-trial-fda” target=”_blank”] by TYLER DURDEN Eager to cash in on the promise of a lucrative market for booster doses of its popular COVID vaccine, Pfizer…